PRAZOSIN PLASMA-CONCENTRATION AND BLOOD-PRESSURE REDUCTION

被引：29

作者：

LAROCHELLE, P

DUSOUICH, P

HAMET, P

LAROCQUE, P

ARMSTRONG, J

机构：

[1] HOTEL DIEU,INST CLIN RES,MONTREAL H2W 1T8,QUEBEC,CANADA

[2] UNIV MONTREAL,DEPT MED & PHARMACOL,MONTREAL H3C 3J7,QUEBEC,CANADA

来源：

关键词：

D O I：

10.1161/01.HYP.4.1.93

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：93 / 101

页数：9

共 16 条

[1] PRAZOSIN, PHARMACOKINETICS AND CONCENTRATION EFFECT
BATEMAN, DN
HOBBS, DC
TWOMEY, TM
STEVENS, EA
RAWLINS, MD
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 177 - 181
[2] PRAZOSIN - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HYPERTENSION
BROGDEN, RN
HEEL, RC
SPEIGHT, TM
AVERY, GS
[J]. DRUGS, 1977, 14 (03) : 163 - 197
[3] CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, P514
[4] CAVERO T, 1977, CLIN EXP PHARM PH S3, V4, P61
[5] Constantine J. W., 1973, HYPERTENSION MECHANI, P429
[6] SELECTIVITY OF BLOCKING-AGENTS FOR PRESYNAPTIC AND POSTSYNAPTIC ALPHA-ADRENOCEPTORS
DOXEY, JC
SMITH, CFC
WALKER, JM
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (01) : 91 - 96
[7] GRAHAM RM, 1977, J PHARMACOL EXP THER, V201, P747
[8] GRAHAM RM, 1976, BRIT MED J, V2, P1283
[9] HESS HJ, 1974, PRAZOSIN EVALUATION, P3
[10] CLINICAL PHARMACOKINETICS OF PRAZOSIN
JAILLON, P
[J]. CLINICAL PHARMACOKINETICS, 1980, 5 (04) : 365 - 376